These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6993030)

  • 21. [Prolonged release microcapsules of insulin for complement of the basal secretion].
    Ogawa Y; Takenaga M; Yamaguchi Y; Igarashi R; Mizushima Y
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():542-7. PubMed ID: 12387048
    [No Abstract]   [Full Text] [Related]  

  • 22. Understanding insulin: the old and new.
    Wilson HK; Field JB
    Adv Intern Med; 1984; 29():357-84. PubMed ID: 6369929
    [No Abstract]   [Full Text] [Related]  

  • 23. Porcine and human insulin absorption from subcutaneous tissues in normal and insulin-dependent diabetic subjects: a deconvolution-based approach.
    Nosadini R; De Kreutzenberg S; Duner E; Iori E; Avogaro A; Trevisan R; Fioretto P; Doria A; Merkel C; Cobelli C
    J Clin Endocrinol Metab; 1988 Sep; 67(3):551-9. PubMed ID: 3045144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Soluble long-acting insulin analogues].
    Yokono K
    Nihon Rinsho; 1997 Nov; 55 Suppl():306-9. PubMed ID: 9434485
    [No Abstract]   [Full Text] [Related]  

  • 25. Absorption kinetics of subcutaneously injected insulin. Evidence for degradation at the injection site.
    Berger M; Halban PA; Girardier L; Seydoux J; Offord RE; Renold AE
    Diabetologia; 1979 Aug; 17(2):97-9. PubMed ID: 488572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Action profile of cobalt(III)-insulin. A novel principle of protraction of potential use for basal insulin delivery.
    Kurtzhals P; Ribel U
    Diabetes; 1995 Dec; 44(12):1381-5. PubMed ID: 7589842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous insulin infusion to simulate subcutaneous absorption. Bioavailability and metabolic sequelae.
    Watanabe RM; Vølund A; Bergman RN
    Diabetes Care; 1991 Nov; 14(11):1021-30. PubMed ID: 1797482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose insulin infusions in diabetic patients with high insulin requirements.
    Dandona P; Foster M; Healey F; Greenbury E; Beckett AG
    Lancet; 1978 Aug; 2(8084):283-5. PubMed ID: 79081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood glucose profiles in diabetic rodents using different insulin preparations.
    Schneider S; Weber R; Luippold G
    Arzneimittelforschung; 2004; 54(12):842-6. PubMed ID: 15646368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Human insulin. Subcutaneous absorption, receptor binding and blood glucose control in diabetics].
    Sestoft L; Birch K; Gammeltoft S; Hildebrandt P; Vølund A
    Ugeskr Laeger; 1983 Jun; 145(24):1843-6. PubMed ID: 6351391
    [No Abstract]   [Full Text] [Related]  

  • 31. [Studies on the absorption kinetics of subcutaneously administered insulin].
    Misawa K
    Hokkaido Igaku Zasshi; 1989 Nov; 64(6):792-812. PubMed ID: 2691384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of aprotinin on the absorption of subcutaneously injected regular insulin in normal subjects.
    Berger M; Cüppers HJ; Halban PA; Offord RE
    Diabetes; 1980 Jan; 29(1):81-3. PubMed ID: 6155298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of subcutaneously administered human, porcine and bovine neutral soluble insulin to normal man.
    Owens DR; Jones MK; Birtwell AJ; Burge CT; Jones IR; Heyburn PJ; Hayes TM; Heding LG
    Horm Metab Res; 1984 Dec; 16 Suppl 1():195-9. PubMed ID: 6152435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subcutaneous injection with an insulin pen. Insulin absorption and plasma concentrations of glucose and free insulin.
    de Meijer PH; Lutterman JA
    Neth J Med; 1990 Feb; 36(1-2):4-12. PubMed ID: 2179752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ocular device for the controlled systemic delivery of insulin.
    Simamora P; Lee YC; Yalkowsky SH
    J Pharm Sci; 1996 Oct; 85(10):1128-30. PubMed ID: 8897284
    [No Abstract]   [Full Text] [Related]  

  • 36. In search of the subcutaneous-insulin-resistance syndrome.
    Schade DS; Duckworth WC
    N Engl J Med; 1986 Jul; 315(3):147-53. PubMed ID: 3523242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Action profile of human ultralente insulin compared with human NPH-insulin].
    Starke AA; Heinemann L; Hohmann A; Berger M
    Dtsch Med Wochenschr; 1989 Apr; 114(16):618-22. PubMed ID: 2651061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin pharmacokinetics.
    Binder C; Lauritzen T; Faber O; Pramming S
    Diabetes Care; 1984; 7(2):188-99. PubMed ID: 6376015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absorption kinetics and action profiles after sequential subcutaneous administration of human soluble and lente insulin through one needle.
    Bilo HJ; Heine RJ; Sikkenk AC; van der Meer J; van der Veen EA
    Diabetes Care; 1987; 10(4):466-9. PubMed ID: 3304896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative evaluation of the effectiveness of insulin preparations "Lente GP" and "Insulong" in type 1 diabetes mellitus].
    Kudriakova SV; Belovanova IM; Romanovskaia GA; Kasymov UA
    Sov Med; 1991; (9):75-7. PubMed ID: 1798933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.